Imaging predictors of pleural response in stage IV non–small cell lung cancer
JTCVS Open · 2026-04 · 30 · 101605
DOI: 10.1016/j.xjon.2026.101605 ↗Kurz gefasst
Fachartikel in der Zeitschrift JTCVS Open, 2026-04. Verfasst von Nicolas Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
The relationship between imaging and pathologic findings after systemic therapy in stage IV non-small cell lung cancer with pleural involvement remains unclear. Morphologic and metabolic imaging changes may predict pleural clearance and inform further treatment decisions.
Methods
We reviewed 24 patients with stage IV non-small cell lung cancer and initial pleural involvement who underwent subsequent pulmonary resection between 2016 and 2025. Baseline and preoperative computed tomography and positron emission tomography-computed tomography scans were assessed for primary, nodal, metastatic, and pleural disease. Residual pleural disease (RPD) was defined by pathologically or cytologically confirmed tumor; undetectable pleural disease (UPD) was defined by absence of gross disease or negative tissue/cytology when available. Major pathologic response (≤10% viable tumor) was assessed in the primary tumor.
Results
Seventeen patients (70.8%) had UPD and 7 (29.2%) had RPD. Patients with UPD had greater rates of major pathologic response in the primary tumor (52.9% vs 0%), complete radiologic response of the primary tumor (64.7% vs 0%, P = .014), complete nodal radiologic response (94.1% vs 5.9%, P = .001), and complete metabolic response in both primary (88.2% vs 20.0%, P = .009) and nodal sites (88.2% vs 11.8%, P = .021). Radiologic improvement in pleural disease did not differ between patients with UPD or RPD (52.9% vs 42.9%, P = .652); however, complete metabolic response was more frequent in patients with UPD (64.7% vs 16.7%, P = .069).
Conclusions
Complete radiologic or metabolic response of the primary and nodal sites strongly correlates with UPD at surgery. Residual pleural disease on imaging should not preclude consideration for surgical consolidation. These findings underscore the potential utility of refined, evidence-based imaging criteria to guide multidisciplinary decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex.
- Department of Thoracic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Tex.
- Thoracic Surgery, HealthONE Cardiac and Thoracic Surgical Specialists, Denver, Colo.
Zitieren
APA
Zhou, N., Vlahos, I., Hooda, Z., Hofstetter, W. L., Mehran, R. J., Rajaram, R., Rice, D. C., Sepesi, B., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., Mitchell, K. G., & Antonoff, M. B. (2026). Imaging predictors of pleural response in stage IV non–small cell lung cancer. JTCVS Open, 30, 101605. https://doi.org/10.1016/j.xjon.2026.101605
Vancouver
Zhou N, Vlahos I, Hooda Z, Hofstetter WL, Mehran RJ, Rajaram R, et al. Imaging predictors of pleural response in stage IV non–small cell lung cancer. JTCVS Open. 2026;30:101605. doi:10.1016/j.xjon.2026.101605
BibTeX
@article{Zhou2026,
author = {Zhou, Nicolas and Vlahos, Ioannis and Hooda, Zamaan and Hofstetter, Wayne L and Mehran, Reza J and Rajaram, Ravi and Rice, David C and Sepesi, Boris and Swisher, Stephen G and Vaporciyan, Ara A and Walsh, Garrett L and Mitchell, Kyle G and Antonoff, Mara B},
title = {Imaging predictors of pleural response in stage IV non–small cell lung cancer},
journal = {JTCVS Open},
year = {2026},
volume = {30},
pages = {101605},
doi = {10.1016/j.xjon.2026.101605}
}
EUVIMED